Pfizer’s Centres for Therapeutic Innovation (CTI) has teamed up with seven New York research hospitals to accelerate biomedical research into life-saving medicines, with a focus on biologics.
GSK and Teva will invest in Russian drug manufacturing in response to PM Vladimir Putin’s warning that Pharmas will face restrictions if they fail to boost local production and transfer technology.
Contract Research Organisation (CRO) Quintiles has opened a Phase I facility in Hyderabad, India, citing increasing demand for efficiency in early-phase drug research in the country.
Genzyme will build a second manufacturing plant in Geel, Belgium to ensure it has the capacity to meet demand for its Pompe disease drugs Myozyme and Lumizyme.
Oncology registries may be ineffective for recruiting large, representative samples of adolescent cancer survivors to clinical trials, according to research.
ShangPharma has opened a multi-purpose pharmaceutical development cGMP manufacturing facility in Fengxian, China, and started operations on the initial phase of production.
Ecron Acunova has expanded its Mangalore, India, clinical pharmacology unit to house 80 beds as demand rises from US and Canadian clients for pharmacokinetic and pharmacodynamic (PK/PD) studies.
US CRO INC Research has bought industry consulting group Avos Life Sciences, citing pharma clients’ need to maximize return on R&D and minimize risk as the key driver.
Solvias says its new combined corporate office and analytical lab in Kaiseraugst, Switzerland will improve the speed and efficiency of its contract analysis services.
The FDA has issued guidance on electronic data in clinical trials to help eliminate duplication, reduce transcription errors and promote real-time entry.
Merck plans to cash in on the biogenerics industry after forming a partnership with Parexel to develop copies of biologic drugs within its Merck BioVentures division.
PRO Consulting has expanded its range of Patient Reported Outcomes (PRO) offerings to better support drug and medical device developers using PROs in all stages of their clinical development programs.
Serious consideration was given to transferring MHRA clinical trial functions to the HRA after it faced criticism including reports of unprofessional and intimidating GCP inspections.
NextPharma Technologies will be bought by Sun European Partners, the European adviser to US investment group Sun Capital Partners, in a deal announced late yesterday.
Creation of a “one-stop shop” for health research approval would free the UK from overly burdensome regulations that are stifling innovation, according to a report.
United Parcel Service (UPS) will open four global healthcare distribution centres to accommodate its fast growing healthcare business and a rising global customer base.
Instrument supplier Mocon has taken its business to new heights, literally, by installing two testing units at a Government pharmaceutical laboratory in Lhasa, Tibet.
CRO ReSearch Pharmaceutical Services (RPS) says acquisition buy private equity group Warburg Pincus will provide “financial strength” for future geographic expansion.
Demand for compliant, patient safe packs will help drive the global blister packaging market to a total value of $32.5bn by 2015, according to new research.
The European Medicines Agency (EMA) has highlighted the quality APIs manufactured outside the EU as an area of concern in the draft 2015 road map it unveiled this week.
Merck KGaA has opened a new centre in India to showcase its range of technology solutions to the country’s rapidly expanding pharmaceutical and cosmetics industries.
in-Pharmatechnologist presents a roundup of the latest deals and acquisitions in the pharmaceutical sector with news from Optima, SPI and DPS Engineering.